RESUMO
Endometrial stromal sarcoma (ESS) formerly classified as low-grade endometrial stromal sarcoma is a rare uterine malignancy with a good prognosis despite a tendency to recur. Primary surgical management for ESS includes total abdominal hysterectomy and bilateral salpingo-oophorectomy. Patients with ESS have long disease-free survival rates when treated with primary surgical therapy, but nearly fifty percent of these patients will recur. We present the case of a patient with recurrent ESS who had an excellent response to combined therapy with megestrol and leuprolide.
Assuntos
Neoplasias Brônquicas/epidemiologia , Neoplasias Pulmonares/epidemiologia , Fumar/efeitos adversos , Saúde da Mulher , Neoplasias Brônquicas/etiologia , Neoplasias Brônquicas/história , Feminino , História do Século XV , História do Século XVI , História do Século XVII , História do Século XVIII , História do Século XIX , História do Século XX , Humanos , Neoplasias Pulmonares/etiologia , Neoplasias Pulmonares/história , Fumar/históriaAssuntos
Neoplasias dos Genitais Femininos/radioterapia , Braquiterapia , Neoplasias da Mama/radioterapia , Disgerminoma/radioterapia , Neoplasias do Endométrio/radioterapia , Feminino , Física Médica , Humanos , Neoplasias Ovarianas/radioterapia , Gravidez , Tolerância a Radiação , Radiobiologia , Dosagem Radioterapêutica , Neoplasias Trofoblásticas/radioterapia , Neoplasias do Colo do Útero/radioterapia , Neoplasias Uterinas/radioterapia , Neoplasias Vaginais/radioterapia , Neoplasias Vulvares/radioterapiaRESUMO
Primary prevention of uterine cervix cancer spans the gamut of human papillomavirus vaccine development, dietary adjustment, chemoprevention, and risk reduction. Lifestyle and social behaviors impact on risk for cervical cancer. Before examining the growing body of molecular evidence, animal studies, and phase I clinical trials that suggest that a virus-based vaccine for cervical cancer may soon become a reality, one must reflect on what has gone before in the vaccine-based battle with viral disease.
